The Medical Letter's Avatar

The Medical Letter

@themedicalletter

A nonprofit organization that has provided independent reviews of drugs and therapeutics since 1959. Funded solely by subscriptions and donations. Because the source matters.

24
Followers
25
Following
242
Posts
02.12.2024
Joined
Posts Following

Latest posts by The Medical Letter @themedicalletter

Answer: d
Atopic dermatitis commonly presents in infancy and early childhood and has a relapsing course, often improving by adolescence, but sometimes persisting into or first appearing in adulthood or even old age.

10.03.2026 21:22 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

It’s Trivia Tuesday! This question is from our article Drugs for Atopic Dermatitis medicalletter.org/atderm749a

10.03.2026 21:22 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

Obinutuzumab (Gazyva) for Lupus Nephritis https://medicalletter.org/obinu750c

09.03.2026 18:50 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Depemokimab (Exdensur) for Severe Eosinophilic Asthma https://medicalletter.org/depem750b

06.03.2026 19:29 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Two New Drugs for Gonorrhea https://medicalletter.org/gonor750a

05.03.2026 12:52 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Read our latest issue: https://bit.ly/4l3G51a

#Gonorrhea #EosinophilicAsthma #LupusNephritis #HeartFailure #AML

04.03.2026 15:18 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Answer: d
An increasing number of complicated intra-abdominal infections are caused by multidrug-resistant gram-negative bacteria that express enzymes such as ESBLs and metallo-beta-lactamases.

03.03.2026 19:11 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

It’s Trivia Tuesday! This question is from our article Aztreonam/Avibactam (Emblaveo) for Complicated Intra-Abdominal Infections medicalletter.org/embla748a

03.03.2026 19:11 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis https://secure.medicalletter.org/TML-article-1749e

26.02.2026 21:21 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Comparison Chart: Topical Nonsteroidal Drugs for Atopic Dermatitis https://secure.medicalletter.org/TML-article-1749d

25.02.2026 19:02 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image


In Brief: Extended Duration of Use for Nexplanon https://secure.medicalletter.org/TML-article-1749b

20.02.2026 14:47 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Drugs for Atopic Dermatitis https://medicalletter.org/atderm749a

19.02.2026 15:39 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Read our latest issue medicalletter.org

#AtopicDermatitis #eczema #contraception

18.02.2026 15:13 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

It’s Trivia Tuesday! This question is from our article Oral Semaglutide (Wegovy) for Weight Management https://medicalletter.org/semag747a

Answer: d
Vomiting and diarrhea are also common. Acute gall bladder disease, acute renal failure, and increases in heart rate have been reported.

17.02.2026 20:41 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Denileukin Diftitox (Lymphir) for Cutaneous T-Cell Lymphoma https://medicalletter.org/denil748f

16.02.2026 14:30 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

In Brief: Removal of Suicidality Warning from GLP-1 Agonists for Weight Management https://secure.medicalletter.org/TML-article-1748e

13.02.2026 17:03 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Advance Release In Brief: Rybelsus R2 Rebranded as Ozempic https://bit.ly/4atb4ix

12.02.2026 18:02 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

In Brief: New Warning for Injectable Medroxyprogesterone https://secure.medicalletter.org/TML-article-1747e

11.02.2026 17:13 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

It’s Trivia Tuesday! This question is from our article Risks of Tramadol and Gabapentin Use for Pain https://medicalletter.org/tragab747d

Answer: b
Tramadol is available alone and in a fixed-dose combination with acetaminophen. It is classified as a Schedule IV controlled substance.

10.02.2026 21:05 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

In Brief: Label Changes for Menopausal Hormone Therapy Products
https://secure.medicalletter.org/TML-article-1748d

10.02.2026 15:13 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Sebetralstat (Ekterly) for Treatment of Hereditary Angioedema Attacks https://medicalletter.org/sebet748c

09.02.2026 15:29 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

A Treprostinil Inhaler (Yutrepia) for Pulmonary Hypertension
https://medicalletter.org/trepr748b

06.02.2026 15:51 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Aztreonam/Avibactam (Emblaveo) for Complicated Intra-Abdominal Infections
https://medicalletter.org/embla748a

05.02.2026 15:57 πŸ‘ 1 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

Read our latest issue https://bit.ly/4aaZ1WS

#cIAI #pulmonaryhypertension #HAE #menopause #GLP1

04.02.2026 15:03 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Answer: d
Use of gepotidacin should be avoided in patients with a history of QT-interval prolongation, in those with relevant pre-existing cardiac disease, and in those taking antiarrhythmics or other drugs that prolong the QT interval.

03.02.2026 20:00 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

It’s Trivia Tuesday! This question is from our article Gepotidacin (Blujepa) - A New Antibiotic for Uncomplicated UTI medicalletter.org/gepo745a

03.02.2026 20:00 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image

New Warning for Injectable Medroxyprogesterone secure.medicalletter.org/TML-article-...

30.01.2026 15:41 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Removal of Suicidality Warning from GLP-1 Agonists for Weight Management
Advance Release Article: bit.ly/3ZEZwUc

#GLP1 #weightmanagement

29.01.2026 15:10 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Risks of Tramadol and Gabapentin Use for Pain medicalletter.org/tragab747d

29.01.2026 15:09 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Lumateperone (Caplyta) for Adjunctive Treatment of Depression medicalletter.org/lumat747c

28.01.2026 14:17 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0